Harris JP, Tegoli J, Swanson J, Fisher N, Gavin J, Noades J. A nebulous antibody responsible for crossmatching difficulties (Chido). Vox Sang 1967;12:140–2.10.1111/j.1423-0410.1967.tb03078.x6016836Search in Google Scholar
Swanson J, Olson J, Azar M. Serological evidence that antibodies of Chido-York-Csa specificity are white cell antibodies (abstract). Fed Proc 1971;30:248.Search in Google Scholar
Middleton J, Crookston MC. Chido substance in plasma. Vox Sang 1972;23:256–61.10.1111/j.1423-0410.1972.tb03459.x5081019Search in Google Scholar
Swanson JL. Laboratory problems associated with leukocyte antibodies. In: Seminar on recent advances in immunohematology. Washington, DC: American Association of Blood Banks.1973 121-55.Search in Google Scholar
Middleton J, Crookston MC, Falk JA, et al. Linkage of Chido and HLA. Tissue Antigen 1974;4:366–73.10.1111/j.1399-0039.1974.tb00262.x4414486Search in Google Scholar
Longster G, Giles CM. A new antibody specificity, anti-Rga, reacting with red cell and serum antigen. Vox Sang 1976;30:175–80.10.1111/j.1423-0410.1976.tb02810.x1251581Search in Google Scholar
Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T Jr. Association between the electrophoretically determined C4M haplotype product and partial inhibition of anti-Cha. J Immunogenet 1980;7:301–6.10.1111/j.1744-313X.1980.tb00723.x6161195Search in Google Scholar
Giles CM. A new genetic variant for Chido. Vox Sang 1984;46:149–56.10.1111/j.1423-0410.1984.tb00067.x6710967Search in Google Scholar
Giles CM, Gedde-Dahl T Jr, Robson EB, et al. Rga (Rodgers) and the HLA region: linkage and association. Tissue Antigens 1976;8:143–49.10.1111/j.1399-0039.1976.tb00578.xSearch in Google Scholar
James J, Stiles P, Boyce F, Wright J. The HL-A type of Rg(a-) individuals. Vox Sang 1976;30:214–16.10.1111/j.1423-0410.1976.tb02817.x1251587Search in Google Scholar
O’Neill GJ, Yang SY, Tegoli J, Berger R, Dupont B. Chido and Rodgers blood groups are distinct antigen components of human complement C4. Nature 1978;273:668–70.10.1038/273668a078453Search in Google Scholar
Tilley CA, Romans DG, Crookston MC. Localization of Chido and Rodgers determinants to the C4d fragment of human C4. Nature 1978;273:713 -5.10.1038/276713a083538Search in Google Scholar
Judd WJ, Kraemer K, Moulds JJ. The rapid identification of Chido and Rodgers antibodies using C4d coated red blood cells. Transfusion 1981;21:189–92.10.1046/j.1537-2995.1981.21281178155.xSearch in Google Scholar
Giles CM, Hoffman M, Moulds M, Harris M, Delmasso A. Allo anti-Chido in a Ch-positive patient. Vox Sang 1987;52:129–33.10.1111/j.1423-0410.1987.tb03008.xSearch in Google Scholar
Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159–63.10.1084/jem.173.5.1159Search in Google Scholar
Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens of C3b/C4b receptor. J Immunol 1991;146:3501–7.Search in Google Scholar
Lambin P, LePennec PY, Hauptmann G, et al. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodgers specificity. Vox Sang 1984;47:242–9.10.1111/j.1423-0410.1984.tb01592.xSearch in Google Scholar
Westhoff CM, Sipherd BD, Wylie DE, Toalson LD. Severe anaphylactic reactions following transfusions of platelets to a patient with anti-Ch. Transfusion 1992;32:576–9.10.1046/j.1537-2995.1992.32692367205.xSearch in Google Scholar
Strupp A, Cash K, Uehlinger J. Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients, Transfusion 1998;38:1022–5.10.1046/j.1537-2995.1998.38111299056310.xSearch in Google Scholar
Awdeh ZL, Alper CA. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A 1980;77:3576–80.10.1073/pnas.77.6.3576Search in Google Scholar
Rittner C, Giles CM, Roos MH, Demant P, Mollenhauer E. Genetics of human C4 polymorphism: detection and segregation of rare and duplicated haplotypes. Immunogenetics 1984;19:321–33.10.1007/BF00345405Search in Google Scholar
Roos MH, Giles CM, Demant P, Mollenhuuer E, Rittner C. Rodgers (Rg) and Chido (Ch) determinants on human C4: characterization of two C4B5 subtypes, one of which contains Rg and Ch determinants. J Immunol 1984;133:2634–40.Search in Google Scholar
Yu CY. The complete exon-intron structure of a human complement component C4A gene. DNA sequences, polymorphisms and linkage to 21-hydroxylase gene. J Immunol 1991;146:1057–66.Search in Google Scholar
Yu CY, Campbell RD, Porter RR. A structural model for the location of the Rodgers and Chido antigenic determinants and their correlation with the human complement components C4A/C4B isotypes. J Immunogenet 1988;27:399–405.10.1007/BF00364425Search in Google Scholar
Belt KT, Carroll MC, Porter RR. The structural basis of the multiple forms of human complement component C4. Cell 1984;36:907–14.10.1016/0092-8674(84)90040-0Search in Google Scholar
Blanchong CA, Chung EK, Rupert KL, et al. Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues Slp and C4. Int Immunopharmacol 2001;1:365–92.10.1016/S1567-5769(01)00019-4Search in Google Scholar
Law SK, Lichtenberg NA, Levine RP. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci U S A 1980;77:7194–8.10.1073/pnas.77.12.71943504686938964Search in Google Scholar
Dodds AW, Ren X-D, Willis AC, Law SKA. The reaction mechanism of the internal thioester in the human complement component C4. Nature 1996;379:177–9.10.1038/379177a08538770Search in Google Scholar
Carroll MC, Fathallah DM, Bergamaschini L, Alicot EM, Isenman DE. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A. Proc Natl Acad Sci U S A 1990;87:6868–72.10.1073/pnas.87.17.6868546392395880Search in Google Scholar
Colton HR. Genetics and synthesis of components of the complement system. In: Ross GD, ed. Immunobiology of the complement system. An introduction for research and clinical medicine. New York: Academic Press, 1986:174–6.Search in Google Scholar
Uko G, Christiansen FT Dawkins RL, McCann VJ. Reference ranges for serum C4 concentrations in subjects with and without C4 null alleles. J Clin Pathol 1986;39:573–6.10.1136/jcp.39.5.5734999223722409Search in Google Scholar
Moulds JM, Arnett FC, Giles CM, Hamilton RG. A novel immunoassay for the quantification of human C4 gene products. Complement Inflamm 1990;7:93–101.10.1159/0004631342225796Search in Google Scholar
Chung EK, Yang Y, Rupert KL, et al. Determining the one, two, three, or four long and short loci human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002;71:810–22.10.1086/34277837853812224044Search in Google Scholar
Fukuoka Y, Zia HZ, Sanchez-Munoz LB, Dellinger AL, Escribano L, Schwartz B. Generation of anaphylatoxins by human ²-tryptase form C3, C4, C5. J Immunol 2008;180:6307–16.10.4049/jimmunol.180.9.6307264541418424754Search in Google Scholar
Richani K, Soto E, Romero R, et al. Normal pregnancy is characterized by systemic activation of the complement system. J Matern Fetal Neonate Med 2005;17:239–45.10.1080/14767050500072722142151316147832Search in Google Scholar
Gigli I, Fugita T, Nussenzweig V. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc Natl Acad Sci U S A 1979;76:6596–600.10.1073/pnas.76.12.6596411913293746Search in Google Scholar
Gatenby PA, Barbosa JE, Lachmann PJ. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation. Clin Exp Immunol 1990;79:158–63.10.1111/j.1365-2249.1990.tb05172.x15347442138067Search in Google Scholar
Manderson AP, Pickering MC, Botto M, Walport MJ, Parrish CR. Continual low level activation of the classical complement pathway. J Exp Med 2001;194:747–56.10.1084/jem.194.6.747219596411560991Search in Google Scholar
Giles CM. An update on Rodgers and Chido, the antigenic determinants of human C4. Immunohematology 1989;5:1–6.10.21307/immunohematology-2019-1057Search in Google Scholar
Carroll MC, Palsdottir A, Belt KT, Porter RR. Deletion of complement C4 and 21-hydroxylase genes in the HLA class III region. EMBO J 1985;4:2547–52.10.1002/j.1460-2075.1985.tb03969.x5545422996881Search in Google Scholar
Mauff G, Alper CA, Dawkins RL, et al. C4 nomenclature statement. Complement Inflamm 1991;7:261–8.10.1159/0004631592088664Search in Google Scholar
Barba G, Rittner C, Schneider PM. Genetic basis of human complement C4A deficiency, detection of a point mutation leading to nonexpression. J Clin Invest 1993;91:1681–6.10.1172/JCI1163772881478473511Search in Google Scholar
Atkinson JP, Frank MM. Bypassing complement: evolutionary lessons and future implications. J Clin Invest 2006;116:1215–8.10.1172/JCI28622145122516670764Search in Google Scholar
Martinez OP, Longman-Jacobsen N, Davies R, et al. Genetics of human complement component C4 and evolution of the central MHC. Front Biosci 2001;6:D904-13.10.2741/A652Search in Google Scholar
Dangel AW, Mendoza AR, Baker BJ, et al. The dichotomous size variation of human complement C4 gene is mediated by a novel family of endogenous retroviruses which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 1994;40:425–36.10.1007/BF001778257545960Search in Google Scholar
Mack M, Bender K, Schneider PM. Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 2004;56:321–32.10.1007/s00251-004-0705-y15309346Search in Google Scholar
Yu CY, Campbell RD. Definitive RFLPS to distinguish between the human complement C4/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4null alleles. Immunogenetics 1987;25:383–90.10.1007/BF00396104Search in Google Scholar
Yu CY, Yang Z, Blanchong CA, Miller W. The human and mouse MHC class III region: a parade of the centromeric segment with 21 genes. Immunol Today 2000;21:320–8.10.1016/S0167-5699(00)01664-9Search in Google Scholar
Chung EK, Yang Y, Rupert KL, et al. Determining the one, two, three or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet 2002;71:810–22.10.1086/34277837853812224044Search in Google Scholar
Wu YL, Yang Y, Chung EK, et al. Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res 2008;123:131–41.10.1159/000184700270907719287147Search in Google Scholar
Szilagyi A, Fust G. Diseases associated with low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 2008;123:118–30.10.1159/00018469919287146Search in Google Scholar
Blanchong CA, Zhou B, Rupert KL, et al. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med 2000;191:2183–96.10.1084/jem.191.12.2183219319810859342Search in Google Scholar
Yang Y, Chung EK, Zhou B, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun. 2004;7:98–132.10.1159/00007568914719377Search in Google Scholar
Harley IT, Kaufman KM, Langfeld CD, Harley JB, Kelly JA. Genetic susceptibility to lupus: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 2009;10:285–90.10.1038/nrg2571273769719337289Search in Google Scholar
Crosslin KL, Wiginton KL. The impact of race and ethnicity on disease severity in systemic lupus erythematosus. Ethn Dis 2009;19:301–7.Search in Google Scholar
Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Herbert D, Silverman ED. Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 2009;36:2539–46.10.3899/jrheum.08114119833755Search in Google Scholar
Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991;4:359–95.10.1128/CMR.4.3.3593582031889047Search in Google Scholar
Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009;460:753–7.10.1038/nature08192277542219571809Search in Google Scholar
Mayilyan LR, Weinberger DR, Sim RB. The complement system in schizophrenia. Drug News Perspect 2008;21:200–10.10.1358/dnp.2008.21.4.1213349271948718560619Search in Google Scholar
Sorensen B, Jones JF, Vernon SD, Rajeevan MS. Transcription control of complement activation in an exercise model of chronic fatigue syndrome. Mol Med 2009;15:34–42.10.2119/molmed.2008.00098258311119015737Search in Google Scholar
Sweeten TL, Odell DW, Odell JD, Torres AR. C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism. BMC Med Genet 2008;9:1–7.10.1186/1471-2350-9-1226526018179706Search in Google Scholar
Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease. J Neurochem 2008;106:2080–92.10.1111/j.1471-4159.2008.05558.x257463818624920Search in Google Scholar
Szilagyi A, Fust G. Diseases associated with the low copy number of the C4B gene encoding C4, the fourth component of complement. Cytogenet Genome Res 2008;123:118–30.10.1159/00018469919287146Search in Google Scholar
Arason GJ, Kramer J, Blasko B, et al. Smoking and a complement gene polymorphism interact in promoting cardiovascular disease morbidity and mortality. Clin Exp Immunol 2007;149:132–8.10.1111/j.1365-2249.2007.03391.x194202517425651Search in Google Scholar
Seppänen M, Suvilehto J, Lokki M-L, et al. Immunoglobulins and complement factor C4 in adult rhinosinusitis. Clin Exp Immunol 2006;145:219–27.10.1111/j.1365-2249.2006.03134.x180967116879240Search in Google Scholar
Arason GJ, Geirsson AJ, Kolka R, Vikingsdottir TH, Valdimarrson H. Deficiency of complement dependent prevention of immune precipitation in systemic sclerosis. Ann Rheum Dis 2002;61:257–60.10.1136/ard.61.3.257175403011830434Search in Google Scholar
Lhotta K, Auinger M, Kronenberg F, Irsigler K, Konig P. Polymorphism of complement C4 and susceptibility to IDDM and microvascular complications. Diabetes Care 1996;19:53–5.10.2337/diacare.19.1.538720534Search in Google Scholar
Ratanachaiyavong S, Demaine AG, Campbell RD, McGregore AM. Heat shock protein 70 (HS70) and complement C4 genotypes in patients with hyperthyroid Graves’ disease. Clin Exp Immunol 1991;84:48–52.Search in Google Scholar
Wyatt RJ, Julian BA, Woodford SY. C4A deficiency and poor prognosis in patients with IgA nephropathy. Clin Nephrol 1991;36:1–5.Search in Google Scholar
Hillarby MC, Strachan T, Grennan DM. Molecular characterisation of C4 null alleles found in Felty’s syndrome. Ann Rheum Dis 1990;49:763–7.10.1136/ard.49.10.763Search in Google Scholar
Wyatt RJ, Wang C, Hudson EC, et al. Complement phenotypes in patients with psoriasis. Hum Hered 1989;39:327–32.10.1159/000153884Search in Google Scholar
Fielder AH, Ollier W Lord DK, et al. HLA class III haplotypes in multicase rheumatoid arthritis families. Hum Immunol 1989;25:75–85.10.1016/0198-8859(89)90072-4Search in Google Scholar
Robb SA, Fielder AHL, Saunders CEL. C4 complement allotypes in juvenile dermatomyositis. Hum Immunol 1988;22:31–8.10.1016/0198-8859(88)90049-3Search in Google Scholar
Briggs DC, Donaldson PT, Hayes P, et al. A major histocompatibility complex class III allotype (C4B2) associated with primary biliary cirrhosis (PBC). Tissue Antigens 1987;29:141–5.10.1111/j.1399-0039.1987.tb01566.x3496684Search in Google Scholar
McLean RH, Wyatt RJ, Julian BA. Complement phenotypes in glomerulonephritis. Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schönlein purpura. Kidney Int 1984;26:855–60.10.1038/ki.1984.2286533396Search in Google Scholar
